Exploitation of the direct cell damaging action of antifungal azoles
- 1 January 1987
- journal article
- editorial
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 6 (1) , 1-3
- https://doi.org/10.1016/0732-8893(87)90108-8
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Irrelevance of growth phase with respect to the Bay n 7133 and ICI 153,066 susceptibilities of Candida albicansDiagnostic Microbiology and Infectious Disease, 1986
- Influence of growth phase on the susceptibility of Candida albicans to butoconazole, oxiconazole, and sulconazoleJournal of Antimicrobial Chemotherapy, 1985
- Fungicidal activity of tioconazole in relation to growth phase of Candida albicans and Candida parapsilosisAntimicrobial Agents and Chemotherapy, 1984
- Inhibition and killing of Candida albicans in vitro by five imidazoles in clinical useAntimicrobial Agents and Chemotherapy, 1984
- Clinical Pharmacokinetics of Systemic Antifungal DrugsClinical Pharmacokinetics, 1983
- Heterogeneity of action of mechanisms among antimycotic imidazolesAntimicrobial Agents and Chemotherapy, 1981
- Mechanisms of Action of the Antimycotic ImidazolesJournal of Investigative Dermatology, 1981
- In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesisAntimicrobial Agents and Chemotherapy, 1980
- Suppression of Cryptococcosis and Histoplasmosis by Ketoconazole in Athymic Nude MiceThe Journal of Infectious Diseases, 1980
- Biochemical effects of miconazole on fungi. II. Inhibition of ergosterol biosynthesis in Candida albicansChemico-Biological Interactions, 1978